CN114377048B - Qiyeshenan dripping pill for treating insomnia and preparation method thereof - Google Patents

Qiyeshenan dripping pill for treating insomnia and preparation method thereof Download PDF

Info

Publication number
CN114377048B
CN114377048B CN202210068373.7A CN202210068373A CN114377048B CN 114377048 B CN114377048 B CN 114377048B CN 202210068373 A CN202210068373 A CN 202210068373A CN 114377048 B CN114377048 B CN 114377048B
Authority
CN
China
Prior art keywords
volume ratio
panax notoginseng
filtrate
ethanol
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210068373.7A
Other languages
Chinese (zh)
Other versions
CN114377048A (en
Inventor
张云生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Jinqi Pharmaceuticals Co ltd
Original Assignee
Yunnan Jinqi Pharmaceuticals Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Jinqi Pharmaceuticals Co ltd filed Critical Yunnan Jinqi Pharmaceuticals Co ltd
Priority to CN202210068373.7A priority Critical patent/CN114377048B/en
Publication of CN114377048A publication Critical patent/CN114377048A/en
Application granted granted Critical
Publication of CN114377048B publication Critical patent/CN114377048B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a Qiyeshenan dripping pill for treating insomnia and a preparation method thereof, in particular provides a method for extracting a high-yield and high-content total saponins from panax notoginseng leaves, and relates to the field of extraction of active ingredients of medicaments. When the panax notoginseng leaves are extracted, the mixed solution of acetic acid and ethanol is used for leaching, so that the active ingredients in the panax notoginseng leaves can be effectively released, the dissolution rate of the total saponins in the panax notoginseng leaves is improved, and then the mixed solution of water, 1-butyl-3-methylimidazolium bromide and a surfactant is used for extracting the filter residue again, so that the yield of the total saponins in the panax notoginseng leaves is improved, the utilization rate of traditional Chinese medicines is improved, and the waste of traditional Chinese medicine resources is reduced; according to the invention, the D101 and AB-8 mixed large-aperture resin with the volume ratio of 1.

Description

Qiyeshenan dripping pill for treating insomnia and preparation method thereof
Technical Field
The invention relates to the field of extraction of active ingredients of medicaments, in particular to a dripping pill for treating insomnia and a preparation method thereof, and particularly relates to an extraction method of a panax notoginseng leaf total saponin raw material.
Background
Folium Notoginseng is leaf of Panax notoginseng (Burk.) F.H.Chen of Araliaceae, has effects of promoting blood circulation for removing blood stasis, relieving swelling and pain, and nourishing and strengthening body constitution. The main active component is total saponins of panax notoginseng leaves. Recent researches show that the main components in the folium Notoginseng are ginsenoside Rb1, ginsenoside Rb3, and Re, gypenoside, notoginsenoside Fa, fc, and Fe. Pharmacological research shows that the total saponins of panax notoginseng leaves have the effects of reducing blood fat, tranquilizing and allaying excitement, improving the organism immunity function of experimental animals, prolonging the life and the like; the analgesic has obvious analgesic effect on pain caused by thermal stimulation and chemical stimulation, the analgesic effect is generated by improving pain threshold and inhibiting central and peripheral pain-causing factors, the effect is quick, and the maintenance time is long; has contraction effect on cerebral vessels and inhibition effect on platelet aggregation.
The aescinate dripping pill is an improved preparation form of the aescinate dripping pill, has the main ingredient of total arasaponin, has pharmacological effects of easing pain, calming, improving sleep and the like, is clinically used for treating insomnia, neurasthenia, migraine and the like, and therefore, the total arasaponin is extracted efficiently, the medicament quality is favorably improved, and the waste of medicament resources is reduced.
At present, the extraction method for the total saponins of panax notoginseng leaves mainly comprises an ethanol extraction method, an ethanol extraction-large-aperture resin method or a water extraction and alcohol precipitation-large-aperture resin method.
For example, chinese patent application 201811645544.8 discloses a panax notoginseng leaf total saponin dropping pill, wherein it also discloses a method for extracting panax notoginseng leaf saponin comprising: decocting: mixing folium Notoginseng with water, decocting, and filtering for the first time to obtain filtrate; separation: adsorbing effective components in the filtrate with macroporous adsorbent resin, and eluting with 50-80% ethanol to obtain eluate rich in arasaponin.
For another example, chinese patent application 201611196949.9 discloses a preparation method of total saponins of folium Notoginseng as raw material of a preparation (QIYESHEN' AN tablet), which is prepared from ginsenoside Rb 3 A method for preparing panax notoginseng leaf total saponins with the content as an evaluation index. The method comprises the following steps: 1) Coarsely crushing folium Notoginseng, and extracting with solvent selected from one of water and 70% ethanol to obtain folium Notoginseng extractive solution; 2) After the relative density of the obtained panax notoginseng leaf extract concentrated juice is 1.10-1.25 (60 ℃), adding ethanol to ensure that the alcohol content is 50% -70% or adding 3-7 times of water for water precipitation, standing and separating, and taking supernatant; 3) Decolorizing the supernatant with macroporous resin, eluting with water and low concentration ethanol, eluting with 70% ethanol, collecting eluate, recovering ethanol, concentrating, and drying. The folium Notoginseng total saponin obtained by the preparation method has high content, feasible production and stable process, and improves quality controllability of folium Notoginseng total saponin, thereby ensuring quality and effectiveness of the product, QIYESHEN' AN tablet, and facilitating standardized production of medicine.
However, the content of the panax notoginseng leaf total saponins obtained by the existing preparation method is lower, and the requirement cannot be better met, so that a preparation method of the panax notoginseng leaf tranquilizing dripping pill needs to be provided, and particularly, an extraction method capable of better improving the yield and the content of the panax notoginseng leaf total saponins needs to be developed.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a dripping pill for treating insomnia and a preparation method thereof, in particular to an extraction method of a total saponins of panax notoginseng leaf raw material with high yield and high content.
In order to achieve the purpose, the technical scheme of the invention is as follows:
on one hand, the invention provides a preparation method of a Qiyeshenan dripping pill for treating insomnia, which comprises the following steps:
mixing folium Notoginseng total saponin and polyethylene glycol, melting, making into dripping pill, cooling, and removing coolant attached on the dripping pill to obtain QIYESHEN dripping pill.
The method for extracting the panax notoginseng leaf total saponins raw material comprises the following steps:
(1) Pulverizing folium Notoginseng, extracting with solvent 1, and filtering to obtain residue 1 and filtrate 1;
(2) Adding a solvent 2 into the filter residue 1 obtained in the step (1), performing ultrasonic extraction, filtering to obtain a filter residue 2 and a filtrate 2, discarding the filter residue 2, combining the filtrate 1 and the filtrate 2, and concentrating until no alcohol smell exists to obtain a concentrated solution of the panax notoginseng leaf total saponin extract;
(3) And (3) adding 3 times of water into the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) to dissolve, passing through a large-aperture resin, eluting, concentrating and drying to obtain a panax notoginseng leaf total saponin raw material.
Wherein, the solvent 1 in the step (1) is an ethanol-acetic acid mixed solution, the volume ratio of ethanol to acetic acid is 3-5;
the concentration of the ethanol is 70-80%, and the concentration of the acetic acid is 50-60%;
preferably, the concentration of the ethanol is 70 percent, and the concentration of the acetic acid is 60 percent;
the concentration of the ethanol is 80 percent, and the concentration of the acetic acid is 50 percent.
The feed-liquid ratio of the step (1) is 1; preferably 1.
As a preferred embodiment, the leaching in step (1) above further comprises a quick-freezing and instant-dissolving step, i.e. after the crushed leaves of panax notoginseng are soaked in the solvent 1, the leaves of panax notoginseng are quickly freeze-dried and then melted at room temperature, and the soaking time is 10-20min.
The solvent 2 in the step (2) is a mixed solution of water, 1-butyl-3-methylimidazolium bromide and a surfactant;
the concentration of the 1-butyl-3-methylimidazole bromine salt is 0.5g/mL, and the preparation method comprises the following steps: 5g of 1-butyl-3-methylimidazole bromine salt is dissolved in 10mL of water to prepare the compound.
In the implementation process, the concentration of the surfactant is unexpectedly found to obviously influence the content of the panax notoginseng leaf total saponins, the yield of the panax notoginseng leaf total saponins is reduced due to too low concentration, and the resource waste can be caused due to too high concentration, so that the extraction amount of the panax notoginseng leaf total saponins can not be increased;
in the implementation process, the invention unexpectedly discovers that the volume ratio of the water to the 1-butyl-3-methylimidazolium bromide to the surfactant is controlled to be 60-80 to 10-15, so that the extraction efficiency of the panax notoginseng leaf total saponins can be obviously improved, and the content of the panax notoginseng leaf total saponins is obviously improved.
Preferably, the volume ratio of the water to the 1-butyl-3-methylimidazolium bromide salt to the surfactant is 80.
Wherein the surfactant is a mixture of lauryl glucoside and cocoyl propyl betaine.
The volume ratio of the dodecyl glucoside to the cocoyl propyl betaine is 2-4;
preferably, the volume ratio of the dodecyl glucoside to the cocoyl propyl betaine is 3-4;
still more preferably, the volume ratio of lauryl glucoside to cocoyl propyl betaine is 3.
The mass volume ratio of the filter residue 1 to the solvent 2 is 1; preferably 1.
The ultrasonic frequency is 40-60Hz, and the ultrasonic time is 5-10min; the ultrasonic frequency is 2-3 times.
The step (2) further comprises a step of removing the solvent, and the specific operations are as follows: and mixing the filtrate 1 and the filtrate 2, performing vacuum filtration on the mixed solution, and recovering the solvent.
The large-aperture resin in the step (3) is selected from one or more of D101, AB-8 and X-5;
preferably, the large-aperture resin is D101 or/and AB-8.
In some preferred embodiments, the large pore size resins are D101 and AB-8 in a volume ratio of 1.
The elution is washing by water and ethanol respectively; the specific elution steps are as follows: eluting with water, 30-40% ethanol, and 70% ethanol, and collecting eluate when the color of eluate changes from colorless to brown.
The washing dosage is 4-6BV; the using amount of the 30-40% ethanol is 4-6BV; the using amount of the 70 percent ethanol is 4-6BV.
As some preferred technical schemes, the method for extracting the total saponins of panax notoginseng leaves in the tranquilizing notoginseng drop pills comprises the following steps:
(1) Pulverizing folium Notoginseng, adding mixed solvent of 70-80% ethanol and 50-60% acetic acid at volume ratio of 3-5:1, leaching for 10-20min, rapidly lyophilizing the leaching solution, melting at room temperature, repeating for 1-2 times, and filtering to obtain residue 1 and filtrate 1;
(2) Adding the filter residue 1 obtained in the step (1) into a mixed solution of water, 1-butyl-3-methylimidazole bromine salt and a surfactant in a volume ratio of 60-80; performing ultrasonic treatment for 2-3 times, filtering to obtain residue 2 and filtrate 2, discarding residue 2, mixing filtrate 1 and filtrate 2, and concentrating until there is no alcohol smell to obtain folium Notoginseng total saponin extract concentrate;
(3) Adding 3 times of water into the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) to dissolve, then passing through D101 and AB-8 with the volume ratio of 1.
As a preferred embodiment, the method for extracting total saponins of panax notoginseng leaves from the dripping pill comprises the following steps:
(1) Pulverizing folium Notoginseng, adding mixed solvent of 80% ethanol and 60% acetic acid at volume ratio of 4:1, extracting for 15min, rapidly lyophilizing the extract, melting at room temperature, repeating for 2 times, and filtering to obtain residue 1 and filtrate 1;
(2) Adding the filter residue 1 obtained in the step (1) into a mixed solution of water, 1-butyl-3-methylimidazole bromine salt and a surfactant in a volume ratio of 80; performing ultrasonic treatment for 2 times, filtering to obtain residue 2 and filtrate 2, discarding residue 2, mixing filtrate 1 and filtrate 2, and concentrating until there is no alcohol smell to obtain folium Notoginseng total saponin extract concentrate;
(3) Adding 3 times of water into the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) to dissolve, then passing the concentrated solution through D101 and AB-8 with the volume ratio of 1.
The surfactant is dodecyl glucoside and cocoyl propyl betaine in a volume ratio of 3.
On the other hand, the panax notoginseng leaf total saponins raw material obtained by the extraction method provided by the invention is applied to preparing the panax notoginseng leaf tranquilizing dripping pill.
On the other hand, the invention also provides the aescinate tranquilizing dripping pill prepared by using the panax notoginseng leaf total saponins as raw materials.
Compared with the prior art, the invention has the beneficial effects that:
(1) The extraction method provided by the invention can better extract the panax notoginseng leaf saponins in the panax notoginseng leaves, improves the dissolution rate of the panax notoginseng leaf saponins, reduces the waste of medicine resources and improves the extraction efficiency;
(2) When the panax notoginseng leaf is extracted, firstly, an acetic acid-ethanol mixed solution is used for leaching, and a quick-freezing and instant dissolving mode is adopted, so that the effective components in the panax notoginseng leaf can be effectively released, the dissolution rate of the panax notoginseng leaf total saponins is improved, then, the filter residue is extracted by using a mixed solution of water, 1-butyl-3-methylimidazolium bromide and a surfactant with the volume ratio of 60-80.
(3) According to the invention, in the purification process, D101 and AB-8 mixed large-aperture resin with the volume ratio of 1.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the detailed description and specific examples, while indicating the scope of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.
The reagents used in the practice of the invention are all commercially available reagents.
A dripping pill for treating insomnia, and its preparation method
The method comprises the following steps:
mixing and melting the panax notoginseng leaf total saponins and the polyethylene glycol according to the weight ratio of 1.
Embodiment 1 a method for extracting total saponins from folium Notoginseng in QIYESHEN dripping pill for treating insomnia comprises the following steps:
(1) 1Kg of pseudo-ginseng leaves are crushed, added with a mixed solvent of 70 percent ethanol (6L) and 60 percent acetic acid (2L) (the material-liquid ratio is 1;
(2) Adding water (3336 mL), 1-butyl-3-methylimidazole bromine salt (556 mL) and a surfactant (55.6 mL) into the filter residue 1 (986.9 g) obtained in the step (1) (the material-liquid ratio is 1;
(3) Adding 3 times of water into the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) to dissolve, then passing through D101 and AB-8 with the volume ratio of 1.
The surfactant in the step (2) is dodecyl glucoside and cocoyl propyl betaine in a volume ratio of 4.
Embodiment 2 a method for extracting total saponins from folium Notoginseng in QIYESHEN dripping pill for treating insomnia comprises the following steps:
(1) Pulverizing 1Kg of folium Notoginseng, adding mixed solvent of 80% ethanol (8.3L) and 50% acetic acid (1.7L) (ratio of material to liquid is 1;
(2) Adding water (4896 mL), 1-butyl-3-methylimidazolium bromide (918 mL) and a mixed solution of a surfactant (61.2 mL) into the filter residue 1 (979.2 g) obtained in the step (1) (the material-liquid ratio is 1;
(3) Adding 3 times of water into the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) to dissolve, then passing the concentrated solution through D101 and AB-8 with the volume ratio of 1.
The surfactant in the step (2) is dodecyl glucoside and cocoyl propyl betaine in a volume ratio of 2.
Embodiment 3 a method for extracting total saponins from folium Notoginseng in dripping pill for treating insomnia comprises the following steps:
(1) 1Kg of pseudo-ginseng leaves are crushed, mixed solvent (the material-liquid ratio is 1;
(2) Adding water (4320 mL), 1-butyl-3-methylimidazolium bromide (540 mL) and a mixed solution of a surfactant (54 mL) into the filter residue 1 (982.8 g) obtained in the step (1) (the feed-liquid ratio is 1; performing ultrasonic treatment for 2 times, filtering to obtain residue 2 and filtrate 2, discarding residue 2, mixing filtrate 1 and filtrate 2, and concentrating until there is no alcohol smell to obtain folium Notoginseng total saponin extract concentrate;
(3) And (3) adding 3 times of water into the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) to dissolve, then, passing through D101 and AB-8 with the volume ratio of 1.
The surfactant in the step (2) is dodecyl glucoside and cocoyl propyl betaine in a volume ratio of 3.
Comparative example 1
The difference from example 3 is that: the leaching was performed using only 80% ethanol in the step (1), and other operations and steps were the same as in example 3.
Comparative example 2
The difference from example 3 is that: the leaching was performed using only 60% acetic acid in the step (1), and other operations and steps were the same as in example 3.
Comparative example 3
The difference from example 3 is that: in step (2), only the mixed solution of water and surfactant, i.e., water (4860 mL) and surfactant (54 mL), was added, and the other operations and steps were the same as in example 3.
Comparative example 4
The difference from example 3 is that: in step (2), only a mixed solution of water and 1-butyl-3-methylimidazolium bromide salt was added, that is, water (4374 mL) and 1-butyl-3-methylimidazolium bromide salt (540 mL) were added, and the operation and procedure were otherwise the same as in example 3.
Comparative example 5
The difference from example 3 is that: the surfactant was replaced with tween-20 in step (2), and the other operations and steps were the same as in example 3.
Comparative example 6
The difference from example 3 is that: in the step (2), the mass ratio of the surfactant lauryl glucoside to the surfactant cocoyl propyl betaine was 1.
Comparative example 7
The difference from example 3 is that: only the D101 large pore resin was used in step (3), and the other operations and steps were the same as in example 3.
Comparative example 8
The difference from example 3 is that: the volume ratio of D101 to AB-8 in step (3) was 3, and the other operations and steps were the same as in example 3.
Comparative example 9
A method for preparing total saponins of folium Notoginseng is disclosed in Chinese patent application 201611196949.9.
Effect verification
The results of the determination of the yield and purity of the total saponins of panax notoginseng leaf raw material obtained in the above examples 1 to 3 and comparative examples 1 to 9 are shown in table 1 below.
The purity detection method comprises the following steps: measuring by high performance liquid chromatography (general rule 0512 of Chinese pharmacopoeia).
Chromatographic conditions and system applicability test: octadecylsilane chemically bonded silica is used as a filling agent; acetonitrile is taken as a mobile phase A, 0.2 percent phosphoric acid solution is taken as a mobile phase B, and gradient elution is carried out according to the specification in the following table; the detection wavelength was 203nm. The number of theoretical plates is not less than 6000 calculated according to the peak of ginsenoside Rb 3.
Preparation of control solutions: taking appropriate amount of ginsenoside Rb3 reference substance, precisely weighing, and adding ethanol to obtain solution containing 0.5mg per 1 ml.
Preparation of a test solution: weighing 50mg of the product, accurately weighing, placing in a 10ml measuring flask, dissolving with ethanol, diluting to scale, shaking, filtering, and collecting the filtrate.
The determination method comprises precisely sucking 10 μ L of each of the reference solution and the sample solution, injecting into liquid chromatograph, and determining.
The gradient elution conditions were:
time (minutes) Mobile phase A (%) Mobile phase B (%)
0-19 30→35 70→65
19-21 35→50 65→50
21-26 50 50
TABLE 1
Figure BDA0003481110030000081
Figure BDA0003481110030000091
According to the detection data in table 1 above, it can be seen that the yield and purity of the total saponins of panax notoginseng leaf obtained by the extraction method provided in embodiments 1-3 of the present invention are both high, and especially the yield of the total saponins of panax notoginseng leaf obtained in embodiment 3 is 9.12%, and the purity is 18.61%, which is obviously superior to the existing level. Comparative examples 1-2 changing the solvent of the first extraction, using only ethanol or only acetic acid, may affect the yield of total saponins of panax notoginseng leaves to some extent, but has little effect on purity. Comparative examples 3-4 change the kind of solvent for the second extraction, which also affects the yield of total saponins in panax notoginseng leaves to a certain extent, but has little effect on the purity. Comparative examples 5-6 change the kind or ratio of the surfactant, have a large influence on the yield of the total saponins of panax notoginseng leaf, and have no obvious influence on the purity. Comparative examples 7 to 8 change the types or volume ratios of the large-aperture resins in the purification process, have little influence on the yield of the panax notoginseng leaf total saponins, but obviously influence the purity of the panax notoginseng leaf total saponins, so that the purity is obviously reduced compared with examples 1 to 3. Comparative example 9 the yield and purity of total saponins from leaves of panax notoginseng obtained by extraction using the extraction methods disclosed in the prior art are significantly lower than those provided in examples 1-3 of the present application.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (8)

1. A method for preparing a dripping pill for treating insomnia comprises the following steps: mixing folium Notoginseng total saponin and polyethylene glycol, melting, making into dripping pill, cooling, and removing coolant attached on the dripping pill to obtain QIYESHEN dripping pill; the method is characterized in that: the panax notoginseng leaf total saponins are extracted by the following method, and the method comprises the following steps:
(1) Pulverizing folium Notoginseng, adding solvent 1, extracting, and filtering to obtain residue 1 and filtrate 1;
(2) Adding a solvent 2 into the filter residue 1 obtained in the step (1), performing ultrasonic extraction, filtering to obtain a filter residue 2 and a filtrate 2, discarding the filter residue 2, combining the filtrate 1 and the filtrate 2, and concentrating until no alcohol smell exists to obtain a concentrated solution of the panax notoginseng leaf total saponin extract;
(3) Dissolving the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) in 3 times of water, passing through a large-aperture resin, eluting with water, then eluting with 30-40% ethanol, finally eluting with 70% ethanol, concentrating and drying to obtain a panax notoginseng leaf total saponin raw material;
the solvent 1 in the step (1) is a mixed solution of 70-80% ethanol and 50-60% acetic acid in a volume ratio of 3-5;
the solvent 2 in the step (2) is a mixed solution of water, 1-butyl-3-methylimidazolium bromide and a surfactant in a volume ratio of 60-80; the surfactant is a mixture of dodecyl glucoside and cocoyl propyl betaine in a volume ratio of 2-4;
the large-aperture resin in the step (3) comprises D101 and AB-8 in a volume ratio of 1.
2. The method of claim 1, wherein: the volume ratio of ethanol to acetic acid was 4.
3. The method for producing according to claim 1, characterized in that: the concentration of the ethanol is 70 percent, and the concentration of the acetic acid is 60 percent.
4. The method for producing according to claim 1, characterized in that: the feed-liquid ratio of the step (1) is 1.
5. The production method according to claim 1, characterized in that: the volume ratio of the water to the 1-butyl-3-methylimidazole bromine salt to the surfactant is 80.
6. The method of claim 1, wherein: the mass volume ratio of the filter residue 1 to the solvent 2 is 1.
7. The production method according to claim 1, characterized in that: the panax notoginseng leaf total saponins are extracted by the following method, and specifically comprise the following steps:
(1) Pulverizing folium Notoginseng, adding mixed solvent of 70-80% ethanol and 50-60% acetic acid at volume ratio of 3-5:1, leaching for 10-20min, rapidly lyophilizing the leaching solution, melting at room temperature, repeating for 1-2 times, and filtering to obtain residue 1 and filtrate 1;
(2) Adding the filter residue 1 obtained in the step (1) into a mixed solution of water, 1-butyl-3-methylimidazole bromine salt and a surfactant in a volume ratio of 60-80; performing ultrasonic treatment for 2-3 times, filtering to obtain residue 2 and filtrate 2, discarding residue 2, mixing filtrate 1 and filtrate 2, and concentrating until there is no alcohol smell to obtain folium Notoginseng total saponin extract concentrate;
(3) Adding 3 times of water into the concentrated solution of the panax notoginseng leaf total saponin extract obtained in the step (2) to dissolve, then passing through D101 and AB-8 with the volume ratio of 1.
8. A dripping pill for treating insomnia is characterized in that: prepared by the preparation method of any one of claims 1 to 7.
CN202210068373.7A 2022-01-20 2022-01-20 Qiyeshenan dripping pill for treating insomnia and preparation method thereof Active CN114377048B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210068373.7A CN114377048B (en) 2022-01-20 2022-01-20 Qiyeshenan dripping pill for treating insomnia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210068373.7A CN114377048B (en) 2022-01-20 2022-01-20 Qiyeshenan dripping pill for treating insomnia and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114377048A CN114377048A (en) 2022-04-22
CN114377048B true CN114377048B (en) 2022-10-21

Family

ID=81203362

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210068373.7A Active CN114377048B (en) 2022-01-20 2022-01-20 Qiyeshenan dripping pill for treating insomnia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114377048B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727806A (en) * 2016-12-22 2017-05-31 江西济民可信药业有限公司 A kind of preparation method of sanchi leaf total saposins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727806A (en) * 2016-12-22 2017-05-31 江西济民可信药业有限公司 A kind of preparation method of sanchi leaf total saposins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
咪唑类离子液体用于中草药及蛋白质样品的分离分析方法研究与应用;刘晓洁;《中国优秀硕士学位论文全文数据库•工程科技辑》;20140415;第1-2、7-10页 *

Also Published As

Publication number Publication date
CN114377048A (en) 2022-04-22

Similar Documents

Publication Publication Date Title
CN103933092B (en) The method of Radix Notoginseng total arasaponins in the fresh Radix Notoginseng of a kind of multiplex-enzyme extraction
JP2010536804A (en) Use of an effective fraction of alkaloids derived from mulberry branches to prepare hypoglycemic agents
CN106727806B (en) A kind of preparation method of sanchi leaf total saposins
CN102258588A (en) Preparation method of peony general glycoside
CN109879919B (en) Method for separating and preparing three flavonoid glycosides from spina date seeds
CN103565866A (en) Preparation method of panax notoginseng saponins
CN104127451A (en) Method of simultaneously extracting polyphenol, flavonoids and triterpenes from pomegranate flowers
CN103893774B (en) A kind of beta amylase is extracting the application in Radix Notoginseng total arasaponins
CN114377048B (en) Qiyeshenan dripping pill for treating insomnia and preparation method thereof
CN110025677B (en) Preparation method of rhubarb extract
CN104224867B (en) A kind of desmodium sugar-free particle and preparation method thereof
CN101084955A (en) Method for preparing total ginsenoside
CN113429442B (en) Method for separating tectoridin and tectorigenin from water extraction residues of rhizoma et radix Sichuan blackberry lily
CN101683396A (en) Extraction method of tropaeolum total lavonoids
CN104987354B (en) The method for preparing morroniside
CN109481531B (en) Qi-benefiting and blood-nourishing composition as well as preparation method and application thereof
CN101084954A (en) Method for preparing American ginseng total saponins
CN104069140B (en) A kind of method for preparing desmodium medicinal extract and its particle
CN104072550A (en) Separation method of monoterpene and saponins components in traditional Chinese medicine composition vegetable drug midbody
CN102824550A (en) Method for preparing compound gastrodia elata preparation
CN112641818A (en) Improved preparation process of epimedium extract
CN115518137B (en) Medicine for treating gynecopathy and its preparing process
CN106619794A (en) Refining method of high-stability radix astragali seu hedysari injection solution and radix astragali seu hedysari injection solution
CN113413413A (en) Preparation method and quality detection method of traditional Chinese medicine composition for treating cerebrovascular diseases through meridian rehabilitation method
CN101869605B (en) Method for extracting and separating mulberry leaf flavone and alkaloid composite

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant